Leading scientific and clinical experts from academia and industry will present the latest findings and developments in immunotherapeutics and immunomonitoring. New immunological concepts with clinically translational implications will be discussed, along with evaluations of novel drug targets and therapeutic approaches, the role of biomarkers in immunomonitoring, and the latest data on combinatorial treatments in the clinic.